• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Another trial for the TARGET trial. Author's reply.

作者信息

Hagel Stefan, Pletz Mathias W, Lehmann Thomas

机构信息

Institute for Infectious Diseases and Infection Control, Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.

Center for Sepsis Control and Care (CSCC), Jena University Hospital - Friedrich Schiller University Jena, Jena, Germany.

出版信息

Intensive Care Med. 2022 Jun;48(6):776-777. doi: 10.1007/s00134-022-06670-9. Epub 2022 Mar 23.

DOI:10.1007/s00134-022-06670-9
PMID:35320369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9205821/
Abstract
摘要

相似文献

1
Another trial for the TARGET trial. Author's reply.针对TARGET试验的另一项试验。作者回复。
Intensive Care Med. 2022 Jun;48(6):776-777. doi: 10.1007/s00134-022-06670-9. Epub 2022 Mar 23.
2
Author's reply to Wendling and Prati: "treat-to-target in spondyloarthritis: implications for clinical trial designs".作者对温德林和普拉蒂的回复：“脊柱关节炎的治疗达标：对临床试验设计的影响”
Drugs. 2014 Sep;74(14):1717-8. doi: 10.1007/s40265-014-0289-2.
3
Analysis of the MAVIDOS trial - Author's reply.MAVIDOS试验分析——作者回复
Lancet Diabetes Endocrinol. 2017 May;5(5):328-329. doi: 10.1016/S2213-8587(17)30113-4.
4
The MATRIX trial - Author's reply.MATRIX试验——作者回复
Lancet. 2019 May 4;393(10183):1803-1804. doi: 10.1016/S0140-6736(19)30049-2.
5
Methods and outcome reporting in the PACE trial--Author's reply.“慢性疲劳综合征/肌痛性脑脊髓炎的临床评估与管理（PACE）试验”中的方法与结果报告——作者回复
Lancet Psychiatry. 2015 Apr;2(4):e10-1. doi: 10.1016/S2215-0366(15)00114-5. Epub 2015 Mar 31.
6
Unanswered questions from the Evoke trial - Author's reply.关于“唤起”试验的未解答问题——作者回复
Lancet Neurol. 2020 May;19(5):380-381. doi: 10.1016/S1474-4422(20)30111-3.
7
Author's reply to correspondence 'influenza like illness related clinical trial on AYUSH-64 requires cautious interpretation'.作者对信件《关于AYUSH - 64的流感样疾病相关临床试验需谨慎解读》的回复。
J Ayurveda Integr Med. 2022 Jan-Mar;13(1):100487. doi: 10.1016/j.jaim.2021.07.003. Epub 2021 Dec 27.
8
Key points to consider in the IMPERIAL trial - Author's reply.IMPERIAL试验中需考虑的关键点——作者回复
Lancet. 2019 Jun 22;393(10190):2490. doi: 10.1016/S0140-6736(19)30694-4.
9
Author's reply: Intrapartum management of trial of labour after caesarean delivery: evidence and experience.作者回复：剖宫产术后阴道试产的产时管理：证据与经验
BJOG. 2014 Jun;121(7):911-2. doi: 10.1111/1471-0528.12587.
10
Trial of Furosemide to Prevent Acute Kidney Injury in Critically Ill Children: A Double-Blind, Randomized, Controlled Trial: Author's Reply.呋塞米预防危重症儿童急性肾损伤的试验：一项双盲、随机、对照试验：作者回复
Indian J Pediatr. 2022 May;89(5):527. doi: 10.1007/s12098-022-04100-8. Epub 2022 Mar 23.

引用本文的文献

1
Is therapeutic drug monitoring really helpful for managing piperacillin/tazobactam therapy in critically ill patients?治疗药物监测对危重症患者哌拉西林/他唑巴坦治疗的管理真的有帮助吗？
Intensive Care Med. 2022 Nov;48(11):1676-1678. doi: 10.1007/s00134-022-06830-x. Epub 2022 Aug 9.
2
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's reply.关于脓毒症患者治疗药物监测指导下哌拉西林/他唑巴坦治疗的研究设计问题及额外分析建议。作者回复。
Intensive Care Med. 2022 Jun;48(6):772-773. doi: 10.1007/s00134-022-06669-2. Epub 2022 Mar 15.
3
Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis.关于脓毒症患者治疗药物监测指导下哌拉西林/他唑巴坦治疗的研究设计问题及进一步分析建议
Intensive Care Med. 2022 Jun;48(6):770-771. doi: 10.1007/s00134-022-06648-7. Epub 2022 Feb 18.

本文引用的文献

1
Another trial for the TARGET trial.另一项针对TARGET试验的试验。
Intensive Care Med. 2022 Jun;48(6):774-775. doi: 10.1007/s00134-022-06654-9. Epub 2022 Mar 1.